Cargando…
Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1
Constitutive activation of the β-catenin dependent canonical Wnt signaling pathway, which enhances tumor growth and progression in multiple types of cancer, is commonly observed in melanoma. LEF1 activates β-catenin/TCF4 transcriptional activity, promoting tumor growth and progression. Although seve...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554883/ https://www.ncbi.nlm.nih.gov/pubmed/32933177 http://dx.doi.org/10.3390/ijms21186706 |
_version_ | 1783593877765095424 |
---|---|
author | Kim, Geon-Hee Fang, Xue-Quan Lim, Woo-Jin Park, Jooho Kang, Tae-Bong Kim, Ji Hyung Lim, Ji-Hong |
author_facet | Kim, Geon-Hee Fang, Xue-Quan Lim, Woo-Jin Park, Jooho Kang, Tae-Bong Kim, Ji Hyung Lim, Ji-Hong |
author_sort | Kim, Geon-Hee |
collection | PubMed |
description | Constitutive activation of the β-catenin dependent canonical Wnt signaling pathway, which enhances tumor growth and progression in multiple types of cancer, is commonly observed in melanoma. LEF1 activates β-catenin/TCF4 transcriptional activity, promoting tumor growth and progression. Although several reports have shown that LEF1 is highly expressed in melanoma, the functional role of LEF1 in melanoma growth is not fully understood. While A375, A2058, and G361 melanoma cells exhibit abnormally high LEF1 expression, lung cancer cells express lower LEF1 levels. A luciferase assay-based high throughput screening (HTS) with a natural compound library showed that cinobufagin suppressed β-catenin/TCF4 transcriptional activity by inhibiting LEF1 expression. Cinobufagin decreases LEF1 expression in a dose-dependent manner and Wnt/β-catenin target genes such as Axin-2, cyclin D1, and c-Myc in melanoma cell lines. Cinobufagin sensitively attenuates cell viability and induces apoptosis in LEF1 expressing melanoma cells compared to LEF1-low expressing lung cancer cells. In addition, ectopic LEF1 expression is sufficient to attenuate cinobufagin-induced apoptosis and cell growth retardation in melanoma cells. Thus, we suggest that cinobufagin is a potential anti-melanoma drug that suppresses tumor-promoting Wnt/β-catenin signaling via LEF1 inhibition. |
format | Online Article Text |
id | pubmed-7554883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75548832020-10-14 Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1 Kim, Geon-Hee Fang, Xue-Quan Lim, Woo-Jin Park, Jooho Kang, Tae-Bong Kim, Ji Hyung Lim, Ji-Hong Int J Mol Sci Article Constitutive activation of the β-catenin dependent canonical Wnt signaling pathway, which enhances tumor growth and progression in multiple types of cancer, is commonly observed in melanoma. LEF1 activates β-catenin/TCF4 transcriptional activity, promoting tumor growth and progression. Although several reports have shown that LEF1 is highly expressed in melanoma, the functional role of LEF1 in melanoma growth is not fully understood. While A375, A2058, and G361 melanoma cells exhibit abnormally high LEF1 expression, lung cancer cells express lower LEF1 levels. A luciferase assay-based high throughput screening (HTS) with a natural compound library showed that cinobufagin suppressed β-catenin/TCF4 transcriptional activity by inhibiting LEF1 expression. Cinobufagin decreases LEF1 expression in a dose-dependent manner and Wnt/β-catenin target genes such as Axin-2, cyclin D1, and c-Myc in melanoma cell lines. Cinobufagin sensitively attenuates cell viability and induces apoptosis in LEF1 expressing melanoma cells compared to LEF1-low expressing lung cancer cells. In addition, ectopic LEF1 expression is sufficient to attenuate cinobufagin-induced apoptosis and cell growth retardation in melanoma cells. Thus, we suggest that cinobufagin is a potential anti-melanoma drug that suppresses tumor-promoting Wnt/β-catenin signaling via LEF1 inhibition. MDPI 2020-09-13 /pmc/articles/PMC7554883/ /pubmed/32933177 http://dx.doi.org/10.3390/ijms21186706 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Geon-Hee Fang, Xue-Quan Lim, Woo-Jin Park, Jooho Kang, Tae-Bong Kim, Ji Hyung Lim, Ji-Hong Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1 |
title | Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1 |
title_full | Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1 |
title_fullStr | Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1 |
title_full_unstemmed | Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1 |
title_short | Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1 |
title_sort | cinobufagin suppresses melanoma cell growth by inhibiting lef1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554883/ https://www.ncbi.nlm.nih.gov/pubmed/32933177 http://dx.doi.org/10.3390/ijms21186706 |
work_keys_str_mv | AT kimgeonhee cinobufaginsuppressesmelanomacellgrowthbyinhibitinglef1 AT fangxuequan cinobufaginsuppressesmelanomacellgrowthbyinhibitinglef1 AT limwoojin cinobufaginsuppressesmelanomacellgrowthbyinhibitinglef1 AT parkjooho cinobufaginsuppressesmelanomacellgrowthbyinhibitinglef1 AT kangtaebong cinobufaginsuppressesmelanomacellgrowthbyinhibitinglef1 AT kimjihyung cinobufaginsuppressesmelanomacellgrowthbyinhibitinglef1 AT limjihong cinobufaginsuppressesmelanomacellgrowthbyinhibitinglef1 |